ProVise Management Group »

Corcept Therapeutics Incorporated shares owned by ProVise Management Group

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by ProVise Management Group from 13F filings

Historical chart of ProVise Management Group investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by ProVise Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by ProVise Management Group

Quarter filed Position value Share count Share price at filing
2023-06-30 $1.0M 48k 21.66
2023-03-31 $1.0M 48k 21.66

More positions owned by ProVise Management Group

Ishares Tr Core Div Grwth (DGRO)
Microsoft Corporation (MSFT)
Vanguard Specialized Funds Div App Etf (VIG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Spdr Ser Tr S&p Divid Etf (SDY)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Apple (AAPL)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)

View all positions for ProVise Management Group

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Bank of New York Mellon
Norges Bank Investment Management
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated